BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15975018)

  • 1. Differentiation of CD8 T cells in response to acute and chronic viral infections: implications for HIV vaccine development.
    Miller JD; Masopust D; Wherry EJ; Kaech S; Silvestri G; Ahmed R
    Curr Drug Targets Infect Disord; 2005 Jun; 5(2):121-9. PubMed ID: 15975018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.
    Figueiredo S; Charmeteau B; Surenaud M; Salmon D; Launay O; Guillet JG; Hosmalin A; Gahery H
    Vaccine; 2014 Jan; 32(4):492-501. PubMed ID: 24291199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of the cellular immune response to HIV infection: implications for vaccination.
    McMichael AJ; Callan M; Appay V; Hanke T; Ogg G; Rowland-Jones S
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1007-11. PubMed ID: 11186301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.
    Makedonas G; Betts MR
    Springer Semin Immunopathol; 2006 Nov; 28(3):209-19. PubMed ID: 16932955
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development.
    Harari A; Ellefsen K; Champagne P; Nobile M; Pantaleo G
    Adv Exp Med Biol; 2002; 512():155-64. PubMed ID: 12405200
    [No Abstract]   [Full Text] [Related]  

  • 7. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
    Ahlers JD; Belyakov IM
    Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory CD8 T-cell differentiation during viral infection.
    Wherry EJ; Ahmed R
    J Virol; 2004 Jun; 78(11):5535-45. PubMed ID: 15140950
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
    Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
    J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.
    Rollman E; Smith MZ; Brooks AG; Purcell DF; Zuber B; Ramshaw IA; Kent SJ
    J Immunol; 2007 Oct; 179(7):4571-9. PubMed ID: 17878354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity.
    Su J; Willert C; Comanita L; Peters A; Gilbert PA; Strathdee C; O'Connell PJ; McFadden GD; Dekaban GA
    Virology; 2008 May; 375(1):48-58. PubMed ID: 18291435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.
    Wijesundara DK; Jackson RJ; Tscharke DC; Ranasinghe C
    Vaccine; 2013 Sep; 31(41):4548-55. PubMed ID: 23933364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
    Lhomme E; Richert L; Moodie Z; Pasin C; Kalams SA; Morgan C; Self S; De Rosa SC; Thiébaut R
    PLoS One; 2016; 11(4):e0152952. PubMed ID: 27124598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memories that last forever: strategies for optimizing vaccine T-cell memory.
    Ahlers JD; Belyakov IM
    Blood; 2010 Mar; 115(9):1678-89. PubMed ID: 19903895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and maintenance of human memory cells during viral infection.
    Halwani R; Doroudchi M; Yassine-Diab B; Janbazian L; Shi Y; Said EA; Haddad EK; Sékaly RP
    Springer Semin Immunopathol; 2006 Nov; 28(3):197-208. PubMed ID: 16967292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.